Anyone relying on the particle size results from DLS or liquid particle counters should consider and address how the data will be used and how to assure the quality of the final results. This ...
Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Randomized Controlled Trial ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for bromantane ...
This suite automates the commissioning, qualification, and validation (CQV) of processes, equipment, and systems. It includes three AI-enabled applications: Together, these systems work in tandem to ...
FDA's draft guidance shows gene therapy developers how to use prior knowledge and platform data to accelerate regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results